The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is:

Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?

Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups.

Participants will:

• receive 6 droplets daily of probiotic or placebo for 3 weeks and
• observe and record improvement of diaper rash symptoms each day using a diary.

Inclusion Criteria:

• presence of diaper dermatitis
• age less than two years

Exclusion Criteria:

• previous use of probiotics
• age more than two years
• an acute bacterial infection
• chronic disease
• local use of antibiotics in the anogenital region